Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Fierce Pharma
ASH: J&J pressures CAR-T with Tecvayli combo in 2L myeloma
The Tecvayli-Darzalex combo’s overall survival curve flattened, suggesting the potential of a cure.
Angus Liu
Dec 9, 2025 7:30am
FDA steers CAR-T developers toward randomized superiority trials
Dec 9, 2025 4:33am
ASH: Anito-cel strengthens potential as Kite preps for launch
Dec 7, 2025 11:52am
Tempest strikes all-stock deal for Factor’s CAR-T pipeline, CEO
Nov 19, 2025 12:22pm
'Gilead wants us to rebuild': Why Galapagos can't go extinct
Nov 19, 2025 7:50am
Fierce Pharma
J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T
Nov 12, 2025 11:36am
